VL21CEMAR1/SES112 - Regulatory and Industry Panel

Mar 17, 2021 9:15am ‐ Mar 17, 2021 11:00am

Overview
Comments

Regulatory and Industry Panel | The Regulatory and Industry Panel is one of the highlights of this conference. This session features questions and answers of the most daunting regulatory issues facing regulators and industry at this time. You will learn the most current perspectives of thought leaders regarding your most pressing challenges. The session is completely interactive, providing for a very rich experience. You will not want to miss this session.

Speaker(s):

Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, FDA/ORA

Moderator(s):

David Doleski, Head of Global Quality Audit and External Engagement, Sanofi

Speaker(s):

Jörg ZIMMERMANN, Vice President Vetter Development Service External Affairs, Vetter Pharma Fertigung GmbH & Co KG
Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, FDA/ORA
Thomas J. Arista, Consumer Safety Officer, FDA/ORA
Mr. Rick Friedman, Deputy Director, Office of Manufacturing Quality, FDA/CDER
Brooke Higgins, Senior Policy Advisor for the Global Compliance Branch 3, FDA/CDER
Alyce Maksoud, Team Leader Inspection Section, PIC/S Chair, Tissue & Cells , Australian Government Department of Health (TGA)
Alan Moon, Lead Senior GMDP Inspector, MHRA
Robert Sausville, Director, Division of Case Management, FDA/CBER/OMPT/OCBQ

You must be logged in and own this session in order to post comments.